A family health plan through work now costs $28,303 a year on average, @KFF finds. Costs borne by workers jumped 9% to $7,471 while wages rose just 3.7%. 2027 increases could hit 9.5%.
Read more: tinyurl.com/bdzkww3d
8
Insulin and GLP-1s are FDA-approved peptides. BPC-157 isn’t, and people who took it report migraines, eye pain, and months of fatigue. Like counterfeit GLP-1s, unapproved means untested. Ask your doctor about FDA-approved options.
Read more: tinyurl.com/mrndwk4w
28
U.S. measles cases have topped 4,580 this year, more than double all of 2025, and 96% of patients were unvaccinated or had unknown status. Pennsylvania alone has 1,338 cases and 5 deaths. Two MMR doses are nearly 97% effective.
Read more: tinyurl.com/4jtzhahb
19
43% of U.S. adults didn’t take their medication as prescribed in the past year because of cost, @KFF finds, up from 33% in 2025. Having insurance doesn’t solve the problem: 3 in 10 insured adults under 65 still put off care because of cost.
Read more: tinyurl.com/rap477ap
California is leading the future of cancer detection. We are proud to see @SutterHealth serve as a leading PATHFINDER 2 study site in the nation, advancing research into new tools that could help detect cancers earlier, especially those without routine screening options.
What if one blood test could help detect cancers that often lack routine screening options? 💙
New findings from the PATHFINDER 2 study are providing important evidence about GRAIL’s investigational Galleri® multi-cancer early detection blood test, designed to screen for more than 50 cancers.
Sutter Health was the study’s second-highest enrolling site nationwide, helping connect thousands of adults with research that could shape the future of cancer detection. Led at Sutter by physician-investigators Dr. Charles McDonnell and Dr. Natalia Colocci, the study found 70% of cancers detected by the blood test were those without nationally recommended screening options.
These results show progress in identifying new ways to detect cancer earlier, while researchers continue to study which patients are most likely to benefit and how testing may affect outcomes, follow-up care, cost and access.
Learn more about the study and Sutter’s role in advancing cancer research: bit.ly/47NODUc.
28
Next year, $0-premium standalone Medicare drug plans disappear outside Extra Help, @AARP reports. @KFF says 28% of those enrollees had one in 2026, and all will pay more. Part D's cap rises to $2,400. Open enrollment runs Oct. 15-Dec. 7.
Read more here: tinyurl.com/3wasaw6s
20
California doctors and insurers are suing @CAgovernor and the Legislature over a health care tax insurers say could add about $100 per person a year to premiums. @CMAdocs and health plans say it breaks limits voters set with Prop. 35.
Read more here: tinyurl.com/5pzw6t9m
1
54
Xavier Becerra is running as California’s “health care governor,” pledging to protect Medi-Cal coverage, keep rural clinics open, and lower drug costs. But how will he pay for it with up to $30B a year in federal cuts? Read more: tinyurl.com/mupvjumn
28
A Tennessee couple, one Republican and one Democrat, share one gripe: PBMs. He found his blood pressure med cost less in cash than through his CVS Caremark plan. @KFFHealthNews and @NPR report Tennessee and Arkansas are reining them in.
Read more here: tinyurl.com/4wn2uydf
1
26
John Oliver spent his @LastWeekTonight return on @UnitedHealthGrp Cole Schmidtknecht, 22, died after his inhaler jumped from $60 to $539 through OptumRx. The bipartisan Break Up Big Medicine Act would break up companies like this.
Watch the segment here: tinyurl.com/ypmv8b2x
1
62
The @US_FDA lets drugs to market faster, then requires safety studies after approval. @KFFHealthNews found nearly 600 of those studies running late. @Amgen's Tavneos, linked to dozens of liver injury cases, still hasn't finished its study.
Read more here: tinyurl.com/5n8tju39
2
136
Nearly 25,000 Californians could be moved from a biologic to a cheaper biosimilar next year under SB 1094, signed by @CAgovernor unless their doctor objects. Backers cite savings; rheumatologists and patient groups fear disrupted care.
Read more here:
tinyurl.com/mrywfxzy
2
29
California men die 5+ years before women, and half of male deaths come before 75. @Movember's new report calls for a state plan to reach men where they are. Saturday is #WorldMentalHealthDay, and mental health is men's health too.
Read more here: tinyurl.com/2ucsmnr5
1
18
We’re thrilled to see the @FDA advisory committee recognize the potential of Galleri and the importance of continued innovation in cancer detection #MCED. tinyurl.com/4semn3b8
1
35
A study of 92 million medical records found 1.1 million Americans taking GLP-1s like Ozempic with no obesity or diabetes diagnosis. Off-label use is up 15x since 2021, and experts warn there's little safety data for these patients.
Read more here: tinyurl.com/abzbxjz2
1
38
Great news for California patients! #AB2009, by @PhillipChenCA and @AsmSolache, was signed by @CAgovernor. The bill will modernize source plasma donation regulations and support a more reliable supply of plasma-derived medicines for those who depend on them.
1
46
Dr. Wayne Ho sees how GLP-1s improve his patients’ lives, but the reversal of Medi-Cal coverage adds to the hurdles faced by vulnerable patients who now risk losing the progress they have “fought incredibly hard to achieve.”
Read more @calhealthreport >> tinyurl.com/hma67c26
Going to be a great & informative webinar hosted by @Looms4Lupus! Don't forget to register today to hear from experts on the #340Bprogram and how proposed changes may affect patients.
When: TOMORROW, September 24 at 9:00am PST
Register here: us06web.zoom.us/webinar/regi…
Join @Looms4Lupus for a webinar on proposed changes to the 340B Program and what they could mean for patients, caregivers, and access to care.
📅 Thursday, September 24, 2026
🕘 9:00 AM PT | 12:00 PM ET
💻 Zoom Webinar
🔗 Register today: us06web.zoom.us/webinar/regi…
#Lupus #PatientEducation #HealthcarePolicy #340B #PatientAdvocacy #HealthEquity #Looms4Lupus
3
95
Policymakers reversed #GLP1 coverage due to budget concerns. But there is a greater cost: undoing health equity for the millions of #LGBTQ+ Californians who rely on Medi-Cal to treat and manage #obesity.
From Dr. Sera Ramadan, DO via @GlendaleNews_P >> tinyurl.com/4cud45jz
2
126
Behind #AB2009 are real patients, families, and caregivers who rely on plasma-derived medicines every day. We urge @CAgovernor to sign this bill into law and ensure California’s policies keep pace with patient need.







